Literature DB >> 10556004

Clinical and histological predictors of contralateral breast cancer.

J Kollias1, I O Ellis, C W Elston, R W Blamey.   

Abstract

AIMS: Women previously treated for primary operable breast cancer are at increased risk of developing cancer in the contralateral breast. The purpose of this study was to assess the annual incidence of metachronous contralateral breast cancer (CBC) and to identify factors that predict for its development.
METHODS: A retrospective study was performed on 3211 women aged </=70 years treated for primary operable breast cancer between 1975 and 1995.
RESULTS: Eighty-three developed CBC prior to locoregional or distant recurrence from the first primary. The clinical incidence of CBC was 6.4 per 1000 women years, three to four times the risk of occurrence of breast cancer in the general female population (or a risk of six to eight times to the remaining breast). Strong family history, age of onset <50 years and lobular histology were significant factors predicting for CBC in univariate and multivariate models. Other clinical factors (previous hormone therapy, chemotherapy, radiotherapy) or histological factors (DCIS, invasive tumour size, grade, vascular invasion, lymph node and oestrogen receptor status) were not significant predictors for CBC.
CONCLUSIONS: In women previously treated for primary operable breast cancer, early age of onset and a strong family history are predictors for the subsequent development of metachronous CBC. Ipsilateral mastectomy with contralateral prophylactic mastectomy with or without immediate breast reconstruction is a reasonable option for a young woman diagnosed with breast cancer and who has a strong family history, particularly if the cancer has histological features suggesting a good prognosis. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10556004     DOI: 10.1053/ejso.1999.0711

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  26 in total

1.  Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.

Authors:  Min Yi; Kelly K Hunt; Banu K Arun; Isabelle Bedrosian; Angelica Gutierrez Barrera; Kim-Anh Do; Henry M Kuerer; Gildy V Babiera; Elizabeth A Mittendorf; Kaylene Ready; Jennifer Litton; Funda Meric-Bernstam
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-20

2.  Application of immediate breast reconstruction with silicon prosthetic implantation following bilateral mammary gland excision in treatment of young patients with early breast cancer.

Authors:  Xi-Ru Li; Yan-Jun Zhang; Jian-Dong Wang; Liu-Quan Cheng; Lei Liu; Jie Li; Yi-Qiong Zheng; Xin Tang; Lei Liu; Ying Gao
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 4.  Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.

Authors:  Abenaa M Brewster; Patricia A Parker
Journal:  Oncologist       Date:  2011-06-14

5.  Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.

Authors:  Julia Prater; Fabio Valeri; Dimitri Korol; Sabine Rohrmann; Silvia Dehler
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-23       Impact factor: 4.553

6.  Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.

Authors:  Patricia A Parker; Susan K Peterson; Isabelle Bedrosian; Melissa A Crosby; Yu Shen; Dalliah M Black; Gildy Babiera; Henry M Kuerer; Jun Ying; Wenli Dong; Scott B Cantor; Abenaa M Brewster
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

7.  Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance.

Authors:  M H See; N Bhoo-Pathy; S Jamaris; A Kiran; D G Evans; C H Yip; N A Taib
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

8.  Prognostic significance of synchronous and metachronous bilateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

9.  Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

Authors:  Min Yi; Funda Meric-Bernstam; Lavinia P Middleton; Banu K Arun; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Henry M Kuerer; Wei Yang; Kelly K Hunt
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

10.  Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.

Authors:  Habib Rahbar; Lucy G Hanna; Constantine Gatsonis; Mary C Mahoney; Mitchell D Schnall; Wendy B DeMartini; Constance D Lehman
Journal:  Radiology       Date:  2014-06-16       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.